Releases Radical New Respiratory Sporting Technology
Melbourne, Nov 22, 2013 AEST (ABN Newswire) - Medical technology company Rhinomed, (
ASX:RNO) has today released its inaugural product in the Australian market, the radical new respiratory sporting technology, the Turbine(TM).
From today, Australian athletes will have an unfair advantage. Rhinomed's Turbine(TM) can increase airflow through the nose by an average of 38%. Already trialed and used by leading professional cyclists, including Mark O'Brien and Australian Olympian cyclist Rob Crowe AO, the Turbine will provide all athletes with the ability to breathe better.
CEO Michael Johnson said, "We invite every Australian to experience the Turbine(TM) and make every breath count. Not surprisingly, the world's athletes are turning in increasing numbers to natural ways of improving their performance. Our message is clear - All you need is air."
Mr. Johnson said, "Today marks a major milestone for the company. We set a goal in February of having a product in the market this calendar year. Today we delivered on that promise. We have released the Turbine(TM) and revenues are expected to flow from this date. We have put in place a clear and granular program that will deliver sustainable growth for investors."
Rhinomed's initial focus is on the billion dollar Australian sport and exercise market. The program over the coming weeks and months will make full use of social media, and specific product placement and trial as the company expands the number of elite athletes and trainers who not only use the technology, but strongly advocate its use.
Having established a beachhead in Australia, the company will expand its reach through international affiliate sites and distribution channels in 2014. With over 4 million Australian cyclists, 40 million American cyclists and 141.9 million Americans participating in outdoor exercise Rhinomed is at the forefront of a significant global opportunity.
The Turbine is available online now at www.theturbine.com.
You can follow also follow us on Twitter @theturbinecom
In addition to pursuing the opportunity in the global sport and exercise market, Rhinomed is developing a range of high value solutions targeting the over the counter health and well being and clinical markets. The company is currently extending its technology portfolio with a focus on:
- Wellbeing - yoga, pilates, meditation, anxiety and appetite management
- Sleep - snoring and sleep apnea
- Drug delivery - targeting acute migraine and rhinitis and sinusitis.
About the Turbine(TM)
The Turbine(TM) is a revolutionary sporting technology, which can deliver to athletes on average 38% increase in airflow through the nasal passages. The Turbine(TM) product range has been designed for both professional and amateur athletes participating in sports and fitness activities ranging from cycling, triathlon running and other aerobic activities such as altitude training. To purchase a Turbine go to:
http://www.theturbine.com
About Rhinomed Limited
Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global
Follow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring
| ||
|
